Hanall Biopharma Company Overview
- Founded
- 1973

- Status
- Public
- Employees
- 310

- Stock Symbol
- 009420

- Investments
- 3
- Share Price
- $22.42
- (As of Wednesday Closing)
Hanall Biopharma Company General Information
Description
Hanall Biopharma Co Ltd is a part of the healthcare sector. It is one of Korea's leading pharmaceutical companies and is focused on drug delivery, biotherapeutics, and new small molecule discovery. The company's scope comprises of ophthalmology, immunology, cardiovascular treatment and dermatology.
Contact Information
- 6th Fl., I-Space Building, 11-10
- Sincheon-Dong
- Songpa-Gu, 138-922
- South Korea
Hanall Biopharma Company Stock Performance
(As of Wednesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$22.42 | $21.62 | $18.74 - $37.30 | $1.11B | 51.2M | 717K | $0.33 |
Hanall Biopharma Company Financials Summary
In Thousands, USD |
TTM 31-Dec-2020 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 |
---|---|---|---|---|
EV | 1,676,628 | 1,676,628 | 1,521,868 | 1,576,713 |
Revenue | 75,042 | 75,042 | 93,006 | 83,558 |
EBITDA | 16,931 | 16,931 | 15,473 | 3,698 |
Net Income | 16,740 | 16,740 | 16,444 | 3,003 |
Total Assets | 201,786 | 201,786 | 165,221 | 145,134 |
Total Debt | 506 | 506 | 491 | 0 |
Hanall Biopharma Company Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Hanall Biopharma Company‘s full profile, request access.
Request a free trialHanall Biopharma Company Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Sung-Yon Lim | Director, Finance Planning Division | ||
SeungKook Park Ph.D | Executive Vice President & Head, Research |
Hanall Biopharma Company Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
00000000 000 | Hanall Biopharma Company | Founder & Chairman | 000 0000 |
Hanall Biopharma Company Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialHanall Biopharma Company Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Hanall Biopharma Company‘s full profile, request access.
Request a free trialHanall Biopharma Company Investments (3)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000000 | 19-Jul-2019 | 00000 00000 00 | 000.00 | Biotechnology | |
000000000 | 05-Feb-2016 | 00000 00000 00 | 00.00 | Biotechnology | 0000-000 000 |
ImmunoMet | 01-Aug-2015 | Seed Round | 00000 | Biotechnology | 0000-000 000 |